Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant pembrolizumab-related hyperprogression in stage III melanoma.
Ammann NL, Geidel G, Schneider SW, Gebhardt C. Ammann NL, et al. Among authors: gebhardt c. J Dtsch Dermatol Ges. 2021 Sep;19(9):1341-1345. doi: 10.1111/ddg.14535. Epub 2021 Jul 13. J Dtsch Dermatol Ges. 2021. PMID: 34255418 No abstract available.
Current and Future Clinical Applications of ctDNA in Immuno-Oncology.
Stadler JC, Belloum Y, Deitert B, Sementsov M, Heidrich I, Gebhardt C, Keller L, Pantel K. Stadler JC, et al. Among authors: gebhardt c. Cancer Res. 2022 Feb 1;82(3):349-358. doi: 10.1158/0008-5472.CAN-21-1718. Epub 2021 Nov 23. Cancer Res. 2022. PMID: 34815256 Free PMC article. Review.
Successful treatment of PD-1 inhibitor-induced psoriasis with infliximab.
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C, Schneider SW. Hansen I, et al. Among authors: gebhardt c. J Eur Acad Dermatol Venereol. 2023 May;37(5):e621-e623. doi: 10.1111/jdv.18780. Epub 2022 Nov 30. J Eur Acad Dermatol Venereol. 2023. PMID: 36424911 No abstract available.
499 results